Healthcare -
Drug Manufacturers - General - NYSE - US
$ 59.615
-0.00839 %
$ 121 B
Market Cap
-13.52
P/E
BMY - COST OF REVENUE
Cost of Revenue BMY - Bristol-Myers Squibb Company
11.9 B
LAST VALUE
8.57%
2 YEAR CAGR
8.14%
5 YEAR CAGR
11.76%
10 YEAR CAGR